Page last updated: 2024-11-05

propionamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Propionamide is an organic compound with the formula CH3CH2CONH2. It is a colorless solid that is soluble in water and ethanol. It is used as a solvent, a plasticizer, and a starting material for the synthesis of other organic compounds. Propionamide is also found in nature, for example in the seeds of the castor oil plant.'

Cross-References

ID SourceID
PubMed CID6578
CHEMBL ID1235716
CHEBI ID45422
MeSH IDM0106698

Synonyms (45)

Synonym
EN300-15614
CHEMBL1235716
propionic acid amide
wln: zv2
propanimidic acid
propionic amide
nsc-38708
propionimidic acid
nsc38708
brn 0969258
amid kyseliny propionove [czech]
propanimidic acid (van)
propionimidic acid (van)
ai3-21217
nsc 38708
einecs 201-172-1
inchi=1/c3h7no/c1-2-3(4)5/h2h2,1h3,(h2,4,5
propionamide ,
propanamide
79-05-0
DB04161
propionamide, 97%
propylamide
CHEBI:45422 ,
n-propionic amide
P0499
AKOS005177582
amid kyseliny propionove
qk07g0hp47 ,
unii-qk07g0hp47
4-02-00-00725 (beilstein handbook reference)
FT-0631349
propionamide [mi]
STL363023
DTXSID3058820
mfcd00008039
J-524060
F0001-2069
Z33546482
propionamide, vetec(tm) reagent grade, 97%
CS-W016688
Q3082378
SY048276
STR08476
O12053

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In the BaF3-TEL-cKIT-T670I isogenic cell inoculated xenograft mouse model, 35 exhibited dose dependent tumor growth suppression efficacy and 100 mg/kg dosage provided 47."( Discovery of N-((1-(4-(3-(3-((6,7-Dimethoxyquinolin-3-yl)oxy)phenyl)ureido)-2-(trifluoromethyl)phenyl)piperidin-4-yl)methyl)propionamide (CHMFL-KIT-8140) as a Highly Potent Type II Inhibitor Capable of Inhibiting the T670I "Gatekeeper" Mutant of cKIT Kina
Bai, M; Chen, C; Hu, C; Hu, Z; Li, B; Liu, F; Liu, J; Liu, Q; Liu, X; Qi, Z; Ren, T; Wang, A; Wang, B; Wang, L; Wang, W; Wu, H; Wu, J; Ye, L; Yu, K; Zhang, S; Zou, F, 2016
)
0.64
" The results of the phase I study showed mizagliflozin increased stool frequency and loosened stool consistency; these effects increased progressively with an increase in the dosage and the number of doses of mizagliflozin."( Mizagliflozin, a novel selective SGLT1 inhibitor, exhibits potential in the amelioration of chronic constipation.
Asari, T; Fujimori, Y; Fushimi, N; Inoue, T; Isaji, M; Kobayashi, M; Kurooka, T; Nishibe, H; Onozato, T; Takeda, H; Takemura, M, 2017
)
0.46
" The analgesic efficacy of pH-dependent opioids has not been studied during the evolution of inflammation, where fluctuating tissue pH and repeated therapeutic dosing could influence analgesia and side effects."( Evolving acidic microenvironments during colitis provide selective analgesic targets for a pH-sensitive opioid.
Alizadeh, E; Bunnett, NW; Degro, CE; Guzman-Rodriguez, M; Hurlbut, D; Jiménez-Vargas, NN; Lomax, AE; Reed, DE; Stein, C; Tsang, Q; Vanner, SJ; Yu, Y, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
monocarboxylic acid amideA carboxamide derived from a monocarboxylic acid.
primary fatty amideA primary carboxamide RC(=O)NH2 resultng from the formal condensation of the carboxy group of a fatty acid with ammonia.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1134605Oil-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID1134606Et2O-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (60)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (13.33)18.7374
1990's9 (15.00)18.2507
2000's17 (28.33)29.6817
2010's21 (35.00)24.3611
2020's5 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.44 (24.57)
Research Supply Index4.13 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index78.22 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (51.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (4.92%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other58 (95.08%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]